The National Institutes of Health gave Cincinnati Children's Hospital a $12 million grant, wcpo.com reported.
The grant will be used to conduct the first clinical trial to determine medication choices to prevent migraines in children and teens.
More than 6 million children and adults in the U.S. are affected by migraines. Currently, there is no FDA approved medication for migraine prevention for children.
The trial will be a five-year study at 40 sites throughout the U.S., led by Dr. Andrew Hershey and Scott Powers...
No comments:
Post a Comment